Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,346 | Dovepress* | 6,590+ | 1,076 | 7,666 | |
| PubMed Central* | 756 | 255 | 1,011 | ||
| Totals | 7,346 | 1,331 | 8,677 | ||
| *Since 18 October 2018 | |||||
View citations on PubMed Central and Google Scholar